Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)
NCT ID: NCT06198491
Last Updated: 2024-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
102 participants
INTERVENTIONAL
2024-03-29
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors
NCT04113902
The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women
NCT07097766
The Effect of Face-to-face and Online Health Education on Women's Cervical Cancer Knowledge, Health Beliefs and Screening
NCT06021496
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
NCT07320157
Effect of HPV Education on Women's Knowledge
NCT07231263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is known that it is crucial to emphasize correct information, not to repeat or point out inaccuracies when taking action to combat false beliefs or myths. In the context of the COVID-19 pandemic, the importance of this approach has been frequently emphasized in the guidance contained in the confirmatory information on misinformation and disinformation. In our study, we want to compare the effectiveness of education models in which false beliefs or myths about HPV are conveyed before or after the current information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training for HPV misbeliefs 1
Participants will receive misbeliefs about HPV; training where misbeliefs are mentioned before the current information.
Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge
Training for HPV misbeliefs 2
Participants will receive misbeliefs about HPV; training where misbeliefs are mentioned after the current information.
Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misbeliefs about HPV training
Intervention trainings mentioned false beliefs before or after the current knowledge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18 years and older
* Those who agree to participate in the study
Exclusion Criteria
* Those who not agree to participate in the study
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Selva Dilan Golbasi Koc
Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eskisehir Osmangazi University Public Health Department
Odunpazari, Eskişehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-80558721-050.99-413737
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.